Alnylam Pharmaceuticals Statistics

Total Valuation

ALNY has a market cap or net worth of $18.17 billion. The enterprise value is $17.04 billion.

Market Cap	18.17B
Enterprise Value	17.04B

Important Dates

The next confirmed earnings date is Thursday, May 2, 2024, before market open.

Earnings Date	May 2, 2024
Ex-Dividend Date	n/a

Share Statistics

ALNY has 126.45 million shares outstanding. The number of shares has increased by 2.64% in one year.

Shares Outstanding	126.45M
Shares Change (YoY)	+2.64%
Shares Change (QoQ)	-4.35%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	95.04%
Float	125.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.94
Forward PS	9.66
PB Ratio	n/a
P/FCF Ratio	433.24
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	406.21

Financial Position

The company has a current ratio of 3.08

Current Ratio	3.08
Quick Ratio	2.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	31.12
Interest Coverage	-2.58

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-12.20%
Return on Capital (ROIC)	-26.01%
Revenue Per Employee	$870,615
Profits Per Employee	-$209,639
Employee Count	2,100
Asset Turnover	0.51
Inventory Turnover	2.85

Taxes

In the past 12 months, ALNY has paid $6.73 million in taxes.

Income Tax	6.73M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.91% in the last 52 weeks. The beta is 0.40, so ALNY's price volatility has been lower than the market average.

Beta (1Y)	0.40
52-Week Price Change	-28.91%
50-Day Moving Average	150.59
200-Day Moving Average	173.05
Relative Strength Index (RSI)	35.95
Average Volume (30 Days)	848,977

Short Selling Information

The latest short interest is 2.50 million, so 1.98% of the outstanding shares have been sold short.

Short Interest	2.50M
Short Previous Month	2.80M
Short % of Shares Out	1.98%
Short % of Float	1.99%
Short Ratio (days to cover)	4.49

Income Statement

In the last 12 months, ALNY had revenue of $1.83 billion and -$440.24 million in losses. Loss per share was -$3.52.

Revenue	1.83B
Gross Profit	1.52B
Operating Income	-282.18M
Pretax Income	-433.52M
Net Income	-440.24M
EBITDA	-215.27M
EBIT	-312.30M
Loss Per Share	-$3.52

Full Income Statement

Balance Sheet

The company has $2.44 billion in cash and $1.31 billion in debt, giving a net cash position of $1.13 billion or $8.97 per share.

Cash & Cash Equivalents	2.44B
Total Debt	1.31B
Net Cash	1.13B
Net Cash Per Share	$8.97
Equity / Book Value	-220.64M
Book Value Per Share	-1.74
Working Capital	2.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $104.16 million and capital expenditures -$62.21 million, giving a free cash flow of $41.95 million.

Operating Cash Flow	104.16M
Capital Expenditures	-62.21M
Free Cash Flow	41.95M
FCF Per Share	$0.34

Full Cash Flow Statement

Margins

Gross margin is 83.02%, with operating and profit margins of -15.43% and -24.08%.

Gross Margin	83.02%
Operating Margin	-15.43%
Pretax Margin	-23.71%
Profit Margin	-24.08%
EBITDA Margin	-11.77%
EBIT Margin	-17.08%
FCF Margin	2.29%

Dividends & Yields

ALNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.64%
Shareholder Yield	-2.64%
Earnings Yield	-2.42%
FCF Yield	0.23%

Dividend Details

Analyst Forecast

The average price target for ALNY is $215.40, which is 49.89% higher than the current price. The consensus rating is "Buy".

Price Target	$215.40
Price Target Difference	49.89%
Analyst Consensus	Buy
Analyst Count	17
Revenue Growth Forecast (5Y)	25.19%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALNY has an Altman Z-Score of 0.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.97
Piotroski F-Score	4